Evidence map›Paper›PMID 37215554›Full record

ArticleFrontiers in cardiovascular medicine2023

Causality of gut microbiome and hypertension: A bidirectional mendelian randomization study.

Yihui Li, Ru Fu, Ruixuan Li, Jianwei Zeng, Tao Liu, Xiaogang Li, Weihong Jiang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Foods (Basel, Switzerland) · 2026
    Article
  7. Observational
  8. Metabolic syndrome and a broken heart: trust your gut or risk your heart.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Fecal Carriage of Multidrug-ResistantBioMed research international · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yihui Li *Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Ru Fu *Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Ruixuan LiDepartment of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Jianwei ZengDepartment of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Tao LiuDepartment of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Xiaogang LiDepartment of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Weihong JiangDepartment of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Third Xiangya Hospital · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: The pathogenesis of hypertension involves a diverse range of genetic, environmental, hemodynamic, and more causative factors. Recent evidence points to an association between the gut microbiome and hypertension. Given that the microbiota is in part determined by host genetics, we used the two-sample Mendelian randomization (MR) analysis to address the bidirectional causal link between gut microbiota and hypertension. Methods: We selected genetic variants ( Results: At the genus level, our MR estimates from gut microbiome to hypertension showed that there were 5 protective factors Conclusion: Altered gut microbiota is a causal factor in the development of hypertension, and hypertension causes imbalances in the intestinal flora. Substantial research is still needed to find the key gut flora and explore the specific mechanisms of their effects so that new biomarkers can be found for blood pressure control.

Indexed as

causalitygenome-Wide association studygut microbiomehypertensionmendelian randomization

Identifiers

PMID37215554
PMCPMC10192878
OpenAlexW4368367796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.